Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...

One is a Cochrane review, published in January, that examined the literature on THC efficacy in treating chronic pain — ...

Concept Medical Inc. announced the presentation of primary results of the SirPAD randomized controlled trial of the company’ ...

Continuous wireless monitoring reduced in-hospital complications and mortality in an Italian pilot trial and significantly ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

Emboline, Inc., a privately held medical technology company developing embolic protection solutions for structural heart procedures, today announced positive results from its pivotal PROTECT H2H ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.